• 검색 결과가 없습니다.

New Born Screening Tests Status of Lysosomal Storage Diseases in Korea

N/A
N/A
Protected

Academic year: 2022

Share "New Born Screening Tests Status of Lysosomal Storage Diseases in Korea"

Copied!
1
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

Lysosomal storage disorders (LSDs) are caused by absent activ- ity of one or more of these enzymes due to mutations of genes en- coding lysosomal hydrolases or enzymes, which results in the ac- cumulation of an intermediate metabolic product. Tandem mass spectrometry (MS/MS) screening for LSDs was first described by Li et al. in 2004. They performed direct multiplex assays for Fabry, Gaucher, Krabbe, Niemann-Pick A/B, and Pompe diseases by using dried blood spots. The findings of these studies demon- strated the usefulness of MS/MS in newborn screening for LSDs.

MS/MS techniques have been also developed for the detection of some MPSs such as Hurler syndrome, Hunter, Maroteaux-Lamy, and Morquio syndrome type A. Recent technological develop- ments enabled automated analysis as well as rapid high through- put screening with minimizing the number of separate incuba- tions. In Korea, our laboratory revised multiplex enzyme reaction conditions and procedures for the assay using MS/MS for 6 LSDs including Niemann-Pick-A/B, Krabbe, Gaucher, Fabry, Pompe disease, and Hurler syndrome in 2010. Assay performance was of the acceptable standard. The assay also enabled unambiguous

differentiation between samples obtained from healthy newborns and patients, suggesting that our method was also effective for newborn screening of LSDs in the Korean population. We also developed methods for measuring iduronate sulfatase activities in DBSs for the screening of Hunter disease which is relatively com- mon in Korea. More detailed status on the NST of LSD in Korea will be presented.

References

1. Cho SE, Kwak JR, Lee H, Seo DH, Song J. Triplex tandem mass spectrometry assays for the screening of 3 lysosomal storage disorders in a Korean population. Clin Chim Acta 2016;454:20-7.

2. Han M, Jun SH, Song SH, Park KU, Kim JQ, Song J. Use of tandem mass spectrometry for newborn screening of 6 ly- sosomal storage disorders in a Korean population. Korean J Lab Med 2011;31:250-6.

Brief Communication

J Mucopolysacch Rare Dis 2017;3(1):35 https://doi.org/10.19125/jmrd.2017.3.1.35

pISSN 2465-8936 · eISSN 2465-9452

Journal of Mucopolysaccharidosis and Rare Diseases

Received April 28, 2017; Revised May 25, 2017; Accepted June 1, 2017 Correspondence to: Junghan Song

Department of Laboratory Medicine, Seoul National University Bundang Hospital and Seoul National University College of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, Korea

Tel: +82-31-787-7691, Fax: +82-31-787-4015, E-mail: songjhcp@gmail.com

35

Copyright © 2017. Association for Research of MPS and Rare Diseases.

CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

New Born Screening Tests Status of Lysosomal Storage Diseases in Korea

Junghan Song

Department of Laboratory Medicine, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seoul Korea

Vol. 1 No. 1, June 2015 (00-00)

ISSN 1234-5678

참조

관련 문서

ABSTRACT - Two laboratory techniques: (1) an in vitro method with two procedures for measuring protein degradabilities and (2) an in vitro method with three

Taking into account that approximately one in two in silico mass spectra of test compound were predicted better than corresponding isomer spectra, the TPR values obtained,

The sensitivity and selectivity of the four types of coating to extract target VOCs from samples were evaluated at 10 ppbv, and the results were illustrated by plotting

Chemical Analysis Laboratory, Korea Research Institute of Chemical Technology, P.O.. Experimental conditions

In the present study, the analytical method using GC-MS for cyanide determination in blood, urine, lung, and skin tissues was validated by assessing its selectivity,

Quantitative analysis was used for the detection limit test, infant formula recovery test, and standard reference material (SRM) 1849a to verify the validity of our

A headspace gas chromatographic mass spectrometric (GC-MS) assay method was developed for the simultaneous determination of methyl tertiary butyl ether (MTBE), tert-butyl

1 Department of Medical Genetics, Metabolism and Endocrinology, National Children’s Hospital, Hanoi, Vietnam, 2 Skeletal Dysplasia Lab, Departments of Biomedical